The Centers for Medicare and Medicaid Services (CMS) has formally announced a significant step in its oversight of the burgeoning Acute Hospital Care at Home (AHCAH) initiative. A Federal Register notice published on August 27, 2026, details CMS's intention to launch a new information collection effort, specifically designed to gather data on the "Quantity, Intensity, and Mix of Services (QIMS)" delivered within the AHCAH program. This move is not merely an administrative update, but a direct response to a legislative directive from Congress, underscoring the federal government's commitment to understanding and shaping the future of home-based acute care.
The Evolving Landscape of Hospital-at-Home Care
The AHCAH initiative represents a pivotal shift in healthcare delivery, allowing hospitals to provide acute-level care to patients in their homes rather than within traditional inpatient facilities. This model has gained traction, particularly since the pandemic, as it offers a potential pathway to increased patient satisfaction, reduced healthcare costs, and improved outcomes for certain patient populations. Key to the AHCAH program's operation are waivers from specific Hospital Conditions of Participation (CoPs). For instance, hospitals participating in AHCAH are typically granted waivers from regulations such as those requiring nursing services to be provided on premises 24 hours a day, seven days a week, and the immediate availability of a registered nurse for any patient's care. These waivers enable the flexibility necessary for hospitals to administer inpatient healthcare services remotely, while theoretically maintaining comparable quality and safety standards.
Participating hospitals, identified by their CMS Certification Number (CCN), receive individual waivers. Patients admitted to AHCAH can originate from an emergency department or be transferred from an existing inpatient hospital unit. The success and long-term viability of this innovative model hinge on its ability to demonstrate effectiveness and safety, which necessitates robust data collection and evaluation.
Congressional Mandate for Evaluation
The driving force behind this new data collection is Section 6210(c) of the Consolidated Appropriations Act of 2026. This legislation specifically mandates that CMS evaluate the care provided through the AHCAH initiative. Congress requires a detailed understanding of the QIMS furnished to patients. This includes granular data points such as the number of clinician visits, the provision of food services, and the extent of pharmacy services received by patients while under the hospital-at-home model. This legislative directive highlights a clear interest from lawmakers in the operational specifics and resource allocation within these programs, likely to inform future policy decisions, funding allocations, and regulatory frameworks.
CMS's role, therefore, is to fulfill this statutory requirement by systematically collecting the necessary information. The agency explicitly states that the collected data will be instrumental in its reporting obligations to Congress, ensuring that legislative bodies have an evidence-based foundation for their oversight and planning.
CMS's Data Collection Strategy
To meet the congressional mandate, CMS has developed a new information collection tool, identified as CMS-10971. This tool is designed to quantify the mix and intensity of services provided within the AHCAH initiative. The agency is now seeking approval from the Office of Management and Budget (OMB) for this information collection under the provisions of the Paperwork Reduction Act of 1995 (PRA).
The PRA requires federal agencies to publish notice of proposed information collections and allow for public comment. The current notice initiates a 60-day comment period, concluding on October 26, 2026. This period offers an opportunity for affected parties to provide input on various aspects of the collection, including the necessity and utility of the information, the accuracy of estimated burden, ways to enhance data quality, and the potential for using automated collection techniques to minimize reporting burdens. CMS estimates that 365 respondents, likely the hospitals participating in AHCAH, will contribute to this effort, resulting in approximately 13,000 total annual responses and an equal number of annual hours dedicated to data submission. This represents a significant administrative undertaking for participating healthcare providers.
Implications and Public Engagement
The implications of this data collection are far-reaching. For participating hospitals, it means an additional administrative responsibility, though one tied directly to the future of the AHCAH model. The data they submit will shape how policymakers perceive the efficiency, resource utilization, and overall efficacy of home-based acute care. For policymakers, the collected QIMS data will offer an unprecedented level of detail to assess whether the AHCAH waivers are achieving their intended purpose without compromising patient safety or quality of care. It will also allow for a more informed discussion on potential expansions, modifications, or even limitations of the program.
Patients and the broader public also stand to benefit from this transparency, as better data can lead to improved care models and resource allocation. The public comment period is a critical juncture, allowing stakeholders including healthcare providers, patient advocacy groups, and other interested parties to directly influence the structure and implementation of this important data collection. Their feedback can help ensure the data collected is both meaningful and imposes a reasonable burden, ultimately contributing to a more effective and sustainable AHCAH program. The insights derived from this collection are poised to inform the trajectory of a healthcare innovation that continues to reshape how acute medical care is delivered across the nation.
